![]() |
| Dr Devi Deliyanti and Professor Jenny Wilkinson-Berka are first and last authors on the paper investigating a drug which reduces oxidative stress in the retina. |
Scientists in Monash University’s Department of Diabetes have demonstrated that a novel drug that suppresses oxidative stress protects the retina against diabetes-induced damage and may prevent vision loss.
Globally, an estimated 70 million people have retinopathy caused by diabetes. The disease is the leading cause of blindness in young adults.
People with diabetes have high levels of glucose in their blood which stimulates oxidative stress, a process that causes damage to many cell types and ultimately cell death.



.jpg)